跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
VOCABRIA 600 mg SUSPENSION INYECTABLE DE LIBERACION PROLONGADA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
VOCABRIA 600 mg SUSPENSION INYECTABLE DE LIBERACION PROLONGADA
Approved
STANDARD
VOCABRIA 600 mg SUSPENSION INYECTABLE DE LIBERACION PROLONGADA
Viiv Healthcare B.V.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jan 20, 2021
Approval ID
c8655307ebf5d4cd
Company
Viiv Healthcare B.V.
Type
Standard
Approval Details
Approval Id
c8655307ebf5d4cd
Drug Cima Aemps Name
VOCABRIA 600 mg SUSPENSION INYECTABLE DE LIBERACION PROLONGADA
Register Number
1201481003
Holder Company Name
Viiv Healthcare B.V.
Marketing Company Name
Laboratorios Viiv Healthcare S.L.
Holder Company Detail Path
/organization/viiv-healthcare-bv
Authorization Date
2021-01-20
Dosage Form
SUSPENSION INYECTABLE DE LIBERACION PROLONGADA
Dose
600 mg
Route Of Administration
VÍA INTRAMUSCULAR
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Viiv Healthcare B.V.
Company Detail Path
/organization/viiv-healthcare-bv
Company Information
Pharmaceutical Company Name
ViiV Healthcare BV
Country Name
Netherlands
Website
http://viivhealthcare.com/nl-nl
Active Ingredients
CABOTEGRAVIR
600 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jan 20, 2021
Approval ID
c8655307ebf5d4cd
Type
Standard
Back to CIMA-AEMPS Approvals